Industry: Service & Software
Published Date: 2024-07-07
Pages: 149 Pages
Report ld: 3232378
Request Sample
Customized Report
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
The global Decentralized Clinical Trial Platforms revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Decentralized Clinical Trial Platforms revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Decentralized Clinical Trial Platforms market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Decentralized Clinical Trial Platforms include Medidata, IQVIA, Veeva Systems, Castor, Delve Health, Jeeva, Signant Health, Clinical Ink, ObvioHealth, THREAD, etc. The global five biggest players hold a share of % in 2023.
Global Decentralized Clinical Trial Platforms Scope and Market Size
Decentralized Clinical Trial Platforms market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Decentralized Clinical Trial Platforms market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Decentralized Clinical Trial Platforms market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Decentralized Clinical Trial Platforms definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Decentralized Clinical Trial Platforms companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Decentralized Clinical Trial Platforms in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Decentralized Clinical Trial Platforms revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Decentralized Clinical Trial Platforms Product Introduction
1.2 Global Decentralized Clinical Trial Platforms Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Decentralized Clinical Trial Platforms Market Size for the Year 2019-2030
1.2.2 United States Decentralized Clinical Trial Platforms Market Size for the Year 2019-2030
1.3 Decentralized Clinical Trial Platforms Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Decentralized Clinical Trial Platforms in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Decentralized Clinical Trial Platforms Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Decentralized Clinical Trial Platforms Market Dynamics
1.4.1 Decentralized Clinical Trial Platforms Industry Trends
1.4.2 Decentralized Clinical Trial Platforms Market Drivers
1.4.3 Decentralized Clinical Trial Platforms Market Challenges
1.4.4 Decentralized Clinical Trial Platforms Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Decentralized Clinical Trial Platforms by Type
2.1 Decentralized Clinical Trial Platforms Market by Type
2.1.1 Cloud Based
2.1.2 Web Based
2.2 Global Decentralized Clinical Trial Platforms Market Size by Type (2019, 2023 & 2030)
2.3 Global Decentralized Clinical Trial Platforms Market Size by Type (2019-2030)
2.4 United States Decentralized Clinical Trial Platforms Market Size by Type (2019, 2023 & 2030)
2.5 United States Decentralized Clinical Trial Platforms Market Size by Type (2019-2030)
3 Decentralized Clinical Trial Platforms by Application
3.1 Decentralized Clinical Trial Platforms Market by Application
3.1.1 Pharmaceutical Companies
3.1.2 Biotechnology Firms
3.1.3 Contract Research Organizations (CROs)
3.1.4 Healthcare Institutions
3.2 Global Decentralized Clinical Trial Platforms Market Size, by Application (2019, 2023 & 2030)
3.3 Global Decentralized Clinical Trial Platforms Market Size by Application (2019-2030)
3.4 United States Decentralized Clinical Trial Platforms Market Size by Application (2019, 2023 & 2030)
3.5 United States Decentralized Clinical Trial Platforms Market Size by Application (2019-2030)
4 Global Decentralized Clinical Trial Platforms Competitor Landscape by Company
4.1 Global Decentralized Clinical Trial Platforms Market Size by Company
4.1.1 Global Key Companies of Decentralized Clinical Trial Platforms, Ranked by Revenue (2023)
4.1.2 Global Decentralized Clinical Trial Platforms Revenue by Player (2019-2024)
4.2 Global Decentralized Clinical Trial Platforms Concentration Ratio (CR)
4.2.1 Decentralized Clinical Trial Platforms Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Decentralized Clinical Trial Platforms in 2023
4.2.3 Global Decentralized Clinical Trial Platforms Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Decentralized Clinical Trial Platforms Head office and Area Served
4.4 Global Key Players of Decentralized Clinical Trial Platforms, Product and Application
4.5 Global Key Players of Decentralized Clinical Trial Platforms, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Decentralized Clinical Trial Platforms Market Size by Company
4.7.1 Key Players of Decentralized Clinical Trial Platforms in United States, Ranked by Revenue (2023)
4.7.2 United States Decentralized Clinical Trial Platforms Revenue by Players (2022, 2023 & 2024)
5 Global Decentralized Clinical Trial Platforms Market Size by Region
5.1 Global Decentralized Clinical Trial Platforms Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Decentralized Clinical Trial Platforms Market Size by Region (2019-2030)
5.2.1 Global Decentralized Clinical Trial Platforms Market Size by Region: 2019-2024
5.2.2 Global Decentralized Clinical Trial Platforms Market Size by Region: 2025-2030
6 Americas
6.1 Americas Decentralized Clinical Trial Platforms Market Size YoY Growth 2019-2030
6.2 Americas Decentralized Clinical Trial Platforms Market Size by Type
6.2.1 Americas Decentralized Clinical Trial Platforms Market Size by Type (2019-2024)
6.2.2 Americas Decentralized Clinical Trial Platforms Market Size by Type (2025-2030)
6.2.3 Americas Decentralized Clinical Trial Platforms Market Share by Type (2019-2030)
6.3 Americas Decentralized Clinical Trial Platforms Market Size by Application
6.3.1 Americas Decentralized Clinical Trial Platforms Market Size by Application (2019-2024)
6.3.2 Americas Decentralized Clinical Trial Platforms Market Size by Application (2025-2030)
6.3.3 Americas Decentralized Clinical Trial Platforms Market Share by Application (2019-2030)
6.4 Americas Decentralized Clinical Trial Platforms Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Decentralized Clinical Trial Platforms Market Size YoY Growth 2019-2030
7.2 EMEA Decentralized Clinical Trial Platforms Market Size by Type
7.2.1 EMEA Decentralized Clinical Trial Platforms Market Size by Type (2019-2024)
7.2.2 EMEA Decentralized Clinical Trial Platforms Market Size by Type (2025-2030)
7.2.3 EMEA Decentralized Clinical Trial Platforms Market Share by Type (2019-2030)
7.3 EMEA Decentralized Clinical Trial Platforms Market Size by Application
7.3.1 EMEA Decentralized Clinical Trial Platforms Market Size by Application (2019-2024)
7.3.2 EMEA Decentralized Clinical Trial Platforms Market Size by Application (2025-2030)
7.3.3 EMEA Decentralized Clinical Trial Platforms Market Share by Application (2019-2030)
7.4 EMEA Decentralized Clinical Trial Platforms Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Decentralized Clinical Trial Platforms Market Size by Type
8.1.1 China Decentralized Clinical Trial Platforms Market Size by Type (2019-2024)
8.1.2 China Decentralized Clinical Trial Platforms Market Size by Type (2025-2030)
8.1.3 China Decentralized Clinical Trial Platforms Market Share by Type (2019-2030)
8.2 China Decentralized Clinical Trial Platforms Market Size by Application
8.2.1 China Decentralized Clinical Trial Platforms Market Size by Application (2019-2024)
8.2.2 China Decentralized Clinical Trial Platforms Market Size by Application (2025-2030)
8.2.3 China Decentralized Clinical Trial Platforms Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Decentralized Clinical Trial Platforms Market Size YoY Growth 2019-2030
9.2 APAC Decentralized Clinical Trial Platforms Market Size by Type
9.2.1 APAC Decentralized Clinical Trial Platforms Market Size by Type (2019-2024)
9.2.2 APAC Decentralized Clinical Trial Platforms Market Size by Type (2025-2030)
9.2.3 APAC Decentralized Clinical Trial Platforms Market Share by Type (2019-2030)
9.3 APAC Decentralized Clinical Trial Platforms Market Size by Application
9.3.1 APAC Decentralized Clinical Trial Platforms Market Size by Application (2019-2024)
9.3.2 APAC Decentralized Clinical Trial Platforms Market Size by Application (2025-2030)
9.3.3 APAC Decentralized Clinical Trial Platforms Market Share by Application (2019-2030)
9.4 APAC Decentralized Clinical Trial Platforms Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 Medidata
10.1.1 Medidata Company Details
10.1.2 Medidata Business Overview
10.1.3 Medidata Decentralized Clinical Trial Platforms Introduction
10.1.4 Medidata Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.1.5 Medidata Recent Development
10.2 IQVIA
10.2.1 IQVIA Company Details
10.2.2 IQVIA Business Overview
10.2.3 IQVIA Decentralized Clinical Trial Platforms Introduction
10.2.4 IQVIA Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.2.5 IQVIA Recent Development
10.3 Veeva Systems
10.3.1 Veeva Systems Company Details
10.3.2 Veeva Systems Business Overview
10.3.3 Veeva Systems Decentralized Clinical Trial Platforms Introduction
10.3.4 Veeva Systems Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.3.5 Veeva Systems Recent Development
10.4 Castor
10.4.1 Castor Company Details
10.4.2 Castor Business Overview
10.4.3 Castor Decentralized Clinical Trial Platforms Introduction
10.4.4 Castor Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.4.5 Castor Recent Development
10.5 Delve Health
10.5.1 Delve Health Company Details
10.5.2 Delve Health Business Overview
10.5.3 Delve Health Decentralized Clinical Trial Platforms Introduction
10.5.4 Delve Health Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.5.5 Delve Health Recent Development
10.6 Jeeva
10.6.1 Jeeva Company Details
10.6.2 Jeeva Business Overview
10.6.3 Jeeva Decentralized Clinical Trial Platforms Introduction
10.6.4 Jeeva Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.6.5 Jeeva Recent Development
10.7 Signant Health
10.7.1 Signant Health Company Details
10.7.2 Signant Health Business Overview
10.7.3 Signant Health Decentralized Clinical Trial Platforms Introduction
10.7.4 Signant Health Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.7.5 Signant Health Recent Development
10.8 Clinical Ink
10.8.1 Clinical Ink Company Details
10.8.2 Clinical Ink Business Overview
10.8.3 Clinical Ink Decentralized Clinical Trial Platforms Introduction
10.8.4 Clinical Ink Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.8.5 Clinical Ink Recent Development
10.9 ObvioHealth
10.9.1 ObvioHealth Company Details
10.9.2 ObvioHealth Business Overview
10.9.3 ObvioHealth Decentralized Clinical Trial Platforms Introduction
10.9.4 ObvioHealth Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.9.5 ObvioHealth Recent Development
10.10 THREAD
10.10.1 THREAD Company Details
10.10.2 THREAD Business Overview
10.10.3 THREAD Decentralized Clinical Trial Platforms Introduction
10.10.4 THREAD Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.10.5 THREAD Recent Development
10.11 Science 37
10.11.1 Science 37 Company Details
10.11.2 Science 37 Business Overview
10.11.3 Science 37 Decentralized Clinical Trial Platforms Introduction
10.11.4 Science 37 Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.11.5 Science 37 Recent Development
10.12 Medable, Clario
10.12.1 Medable, Clario Company Details
10.12.2 Medable, Clario Business Overview
10.12.3 Medable, Clario Decentralized Clinical Trial Platforms Introduction
10.12.4 Medable, Clario Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.12.5 Medable, Clario Recent Development
10.13 Aparito
10.13.1 Aparito Company Details
10.13.2 Aparito Business Overview
10.13.3 Aparito Decentralized Clinical Trial Platforms Introduction
10.13.4 Aparito Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.13.5 Aparito Recent Development
10.14 Viedoc Technologies
10.14.1 Viedoc Technologies Company Details
10.14.2 Viedoc Technologies Business Overview
10.14.3 Viedoc Technologies Decentralized Clinical Trial Platforms Introduction
10.14.4 Viedoc Technologies Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.14.5 Viedoc Technologies Recent Development
10.15 Crucial Data Solutions
10.15.1 Crucial Data Solutions Company Details
10.15.2 Crucial Data Solutions Business Overview
10.15.3 Crucial Data Solutions Decentralized Clinical Trial Platforms Introduction
10.15.4 Crucial Data Solutions Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.15.5 Crucial Data Solutions Recent Development
10.16 Medrio
10.16.1 Medrio Company Details
10.16.2 Medrio Business Overview
10.16.3 Medrio Decentralized Clinical Trial Platforms Introduction
10.16.4 Medrio Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.16.5 Medrio Recent Development
10.17 Alira Health
10.17.1 Alira Health Company Details
10.17.2 Alira Health Business Overview
10.17.3 Alira Health Decentralized Clinical Trial Platforms Introduction
10.17.4 Alira Health Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.17.5 Alira Health Recent Development
10.18 Fortrea
10.18.1 Fortrea Company Details
10.18.2 Fortrea Business Overview
10.18.3 Fortrea Decentralized Clinical Trial Platforms Introduction
10.18.4 Fortrea Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.18.5 Fortrea Recent Development
10.19 Huma
10.19.1 Huma Company Details
10.19.2 Huma Business Overview
10.19.3 Huma Decentralized Clinical Trial Platforms Introduction
10.19.4 Huma Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.19.5 Huma Recent Development
10.20 Cliniv Health Tech
10.20.1 Cliniv Health Tech Company Details
10.20.2 Cliniv Health Tech Business Overview
10.20.3 Cliniv Health Tech Decentralized Clinical Trial Platforms Introduction
10.20.4 Cliniv Health Tech Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.20.5 Cliniv Health Tech Recent Development
10.21 Datacubed Health
10.21.1 Datacubed Health Company Details
10.21.2 Datacubed Health Business Overview
10.21.3 Datacubed Health Decentralized Clinical Trial Platforms Introduction
10.21.4 Datacubed Health Revenue in Decentralized Clinical Trial Platforms Business (2019-2024)
10.21.5 Datacubed Health Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Decentralized Clinical Trial Platforms market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 116
USD 4250.00
(Single User License)
The global Decentralized Clinical Trial Platforms market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 174
USD 4900.00
(Single User License)
The global market for Decentralized Clinical Trial Platforms was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 147
USD 3950.00
(Single User License)
The global Decentralized Clinical Trial Platforms market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 158
USD 2900.00
(Single User License)
The global Decentralized Clinical Trial Platforms market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 118
USD 4250.00
(Single User License)
The global Decentralized Clinical Trial Platforms market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 171
USD 4900.00
(Single User License)
The global market for Decentralized Clinical Trial Platforms was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 143
USD 3950.00
(Single User License)
The global market for Decentralized Clinical Trial Platforms was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 102
USD 2900.00
(Single User License)
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published Date: 2024-07-07
Pages: 109
USD 2900.00
(Single User License)
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published Date: 2024-07-07
Pages: 166
USD 4900.00
(Single User License)
The global Decentralized Clinical Trial Platforms market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 116
The global Decentralized Clinical Trial Platforms market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 174
The global market for Decentralized Clinical Trial Platforms was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 147
The global Decentralized Clinical Trial Platforms market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 158
The global Decentralized Clinical Trial Platforms market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 118
The global Decentralized Clinical Trial Platforms market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 171
The global market for Decentralized Clinical Trial Platforms was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 143
The global market for Decentralized Clinical Trial Platforms was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 102
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published: 2024-07-07
Pages: 109
Decentralized Clinical Trial (DCT) platforms are technology solutions designed to support and conduct clinical trials by leveraging digital tools and remote methodologies. These platforms facilitate the collection, management, and analysis of clinical trial data without the need for participants to visit traditional clinical trial sites. DCT platforms enable more flexible, patient-centric trials, often referred to as virtual or hybrid trials.
Published: 2024-07-07
Pages: 166
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now